ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 143 participants.

Also called NCT05988411

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 143 participants (enrolled count) (from the registry)
Sponsor
  • Vivek Reddy Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05988411
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05988411. Randomized; single masking; primary purpose treatment. Start 2023-12-07 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
Condition
Paroxysmal Atrial Fibrillation
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Renal Denervation
Intervention (Device)
Catheter Ablation
Lead sponsor
Vivek Reddy (class: other)

Record details

Record id
cardio:ct-nct05988411
Content hash
e3d4a31960bd77a6633e47c165f349abae90425408a746acf8dab05a09d307dc